1,823 results on '"Waldmann, Thomas A."'
Search Results
2. Temperature-driven path dependence in Li-ion battery cyclic aging
3. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma
4. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia
5. Analysis and therapeutic targeting of the IL-1R pathway in anaplastic large cell lymphoma
6. Interleukin-15 augments NK cell–mediated ADCC of alemtuzumab in patients with CD52+ T-cell malignancies
7. Arrhenius plots for Li-ion battery ageing as a function of temperature, C-rate, and ageing state – An experimental study
8. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas
9. Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma
10. NF-κB–induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia
11. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma
12. Lithium Redistribution Mechanism within Silicon-Graphite Electrodes: Multi-Method Approach and Method Validation.
13. A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.
14. Essential role of the linear ubiquitin chain assembly complex and TAK1 kinase in A20 mutant Hodgkin lymphoma
15. The implications of IL-15 trans-presentation on the immune response
16. Aging Mechanism For Calendar Aging of Li-Ion Cells With Si/Graphite Anodes
17. Trans -endocytosis of intact IL-15Rα–IL-15 complex from presenting cells into NK cells favors signaling for proliferation
18. A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma
19. IL-2 receptors preassemble and signal in the ER/Golgi causing resistance to antiproliferative anti–IL-2Rα therapies
20. 621 A phase I study of autologous activated NK cells ± rhIL15 in children and young adults with refractory solid tumors
21. Multistep Improvement of Pilot-Scale 21700 Cells for Increased Fast-Charging Capability: Combining Optimized Electrolyte, Cell Design and Fast-Charging Protocol
22. IL-15 enhanced antibody-dependent cellular cytotoxicity mediated by NK cells and macrophages
23. Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
24. Rapid progression of adult T-cell leukemia/lymphoma as tumor-infiltrating Tregs after PD-1 blockade
25. Safety Evaluation of Temperature-Dependent Aging Mechanisms of Li-Ion Batteries Using ARC Tests with Multiple Online Sensors
26. How Cyclic Aging at Different Temperatures Affects Safety of Li-Ion Pouch Cells
27. Gene regulation and suppression of type I interferon signaling by STAT3 in diffuse large B cell lymphoma
28. Development of Zenapax®: A Humanized Anti-Tac Antibody
29. Evaluation of commercial 18650 and 26700 sodium-ion cells and comparison with well-established lithium-ion cells
30. Protection by universal influenza vaccine is mediated by memory CD4 T cells
31. Li plating as unwanted side reaction in commercial Li-ion cells – A review
32. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively
33. IL-2 and IL-15 blockade by BNZ-1, an inhibitor of selective γ-chain cytokines, decreases leukemic T-cell viability
34. Central Memory Self/Tumor-Reactive CD8 + T Cells Confer Superior Antitumor Immunity Compared with Effector Memory T Cells
35. Survival Adjustment of Mature Dendritic Cells by IL-15
36. IL-15/IL-15Rα-Mediated Avidity Maturation of Memory CD8+ T Cells
37. IL-2 and IL-15 Receptor α-Subunits Are Coexpressed in a Supramolecular Receptor Cluster in Lipid Rafts of T Cells
38. Humanized Anti-CD25 (Daclizumab) Inhibits Disease Activity in Multiple Sclerosis Patients Failing to Respond to Interferon β
39. IL-15 Enhances the in vivo Antitumor Activity of Tumor-Reactive CD8 + T Cells
40. Cytokine receptor signaling is required for the survival of ALK− anaplastic large cell lymphoma, even in the presence of JAK1/STAT3 mutations
41. Change of safety by main aging mechanism – A multi-sensor accelerating rate calorimetry study with commercial Li-ion pouch cells
42. Accessory cells precondition naive T cells and regulatory T cells for cytokine-mediated proliferation
43. Data from EGR1 Addiction in Diffuse Large B-cell Lymphoma
44. Data from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
45. Figure S1 from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
46. Supplementary Table 1 from EGR1 Addiction in Diffuse Large B-cell Lymphoma
47. Supplementary Methods, Supplementary Figures 1-10 from EGR1 Addiction in Diffuse Large B-cell Lymphoma
48. Table S1 from IL15 Infusion of Cancer Patients Expands the Subpopulation of Cytotoxic CD56bright NK Cells and Increases NK-Cell Cytokine Release Capabilities
49. Distinct Pathways Involving the FK506-Binding Proteins 12 and 12.6 Underlie IL-2- versus IL-15-Mediated Proliferation of T Cells
50. Coadministration of HIV Vaccine Vectors with Vaccinia Viruses Expressing IL-15 but Not IL-2 Induces Long-Lasting Cellular Immunity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.